- Home
- BBIO vs ATR Comparison
BBIO vs ATR Comparison
Compare BBIO & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- ATR
- Stock Information
- Founded
- BBIO 2015
- ATR 1992
- Country
- BBIO United States
- ATR United States
- Employees
- BBIO N/A
- ATR N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- ATR Plastic Products
- Sector
- BBIO Health Care
- ATR Industrials
- Exchange
- BBIO Nasdaq
- ATR Nasdaq
- Market Cap
- BBIO 8.8B
- ATR 10.2B
- IPO Year
- BBIO 2019
- ATR 1993
- Fundamental
- Price
- BBIO $47.27
- ATR $157.34
- Analyst Decision
- BBIO Strong Buy
- ATR Strong Buy
- Analyst Count
- BBIO 16
- ATR 4
- Target Price
- BBIO $61.50
- ATR $182.50
- AVG Volume (30 Days)
- BBIO 2.2M
- ATR 325.5K
- Earning Date
- BBIO 08-05-2025
- ATR 07-31-2025
- Dividend Yield
- BBIO N/A
- ATR 1.15%
- EPS Growth
- BBIO N/A
- ATR 17.39
- EPS
- BBIO N/A
- ATR 5.47
- Revenue
- BBIO $127,415,000.00
- ATR $3,554,747,000.00
- Revenue This Year
- BBIO $106.33
- ATR $4.36
- Revenue Next Year
- BBIO $54.30
- ATR $5.24
- P/E Ratio
- BBIO N/A
- ATR $28.64
- Revenue Growth
- BBIO N/A
- ATR 0.34
- 52 Week Low
- BBIO $21.72
- ATR $130.85
- 52 Week High
- BBIO $48.68
- ATR $178.03
- Technical
- Relative Strength Index (RSI)
- BBIO 64.57
- ATR 49.73
- Support Level
- BBIO $45.11
- ATR $154.92
- Resistance Level
- BBIO $47.11
- ATR $164.28
- Average True Range (ATR)
- BBIO 1.40
- ATR 2.85
- MACD
- BBIO -0.26
- ATR -0.24
- Stochastic Oscillator
- BBIO 60.53
- ATR 35.32
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.